These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23337595)

  • 1. Next generation personalized animals as an enabling technology in personalized vaccinology.
    Poland GA; Mirochnitchenko O
    Vaccine; 2013 Jan; 31(5):725-7. PubMed ID: 23337595
    [No Abstract]   [Full Text] [Related]  

  • 2. Visionary concept: printable vaccines.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Dec; 8(12):1744. PubMed ID: 23980268
    [No Abstract]   [Full Text] [Related]  

  • 3. [Personalized vaccination?].
    Długońska H
    Wiad Parazytol; 2010; 56(4):315-8. PubMed ID: 21452524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter from the editor.
    Ellis RW; Riedmann EM
    Hum Vaccin Immunother; 2012 Mar; 8(3):281. PubMed ID: 22418878
    [No Abstract]   [Full Text] [Related]  

  • 5. Questions for biotechs.
    Bachmann M
    Hum Vaccin; 2010 Jul; 6(7):527. PubMed ID: 20622523
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanobiotechnology and personalized medicine.
    Jain KK
    Prog Mol Biol Transl Sci; 2011; 104():325-54. PubMed ID: 22093223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine process technology.
    Josefsberg JO; Buckland B
    Biotechnol Bioeng; 2012 Jun; 109(6):1443-60. PubMed ID: 22407777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iPSCs for personalized medicine: what will it take for Africa?
    Fakunle ES
    Trends Mol Med; 2012 Dec; 18(12):695-9. PubMed ID: 23137920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New technologies for new influenza vaccines.
    Shaw A
    Vaccine; 2012 Jul; 30(33):4927-33. PubMed ID: 22579861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing vaccines in the era of genomics: a decade of reverse vaccinology.
    Seib KL; Zhao X; Rappuoli R
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transgenic plants as a medicine production system].
    Okada Y
    Tanpakushitsu Kakusan Koso; 2000 Mar; 45(4):607-13. PubMed ID: 10714178
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of computing technology on pharmaceutical and biotech research.
    Owen J
    IDrugs; 2005 Oct; 8(10):834-7. PubMed ID: 16254804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational and systematic protein purification process development: the next generation.
    Nfor BK; Verhaert PD; van der Wielen LA; Hubbuch J; Ottens M
    Trends Biotechnol; 2009 Dec; 27(12):673-9. PubMed ID: 19815300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioreactor systems for the production of biopharmaceuticals from animal cells.
    Warnock JN; Al-Rubeai M
    Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health technology assessments in personalized medicine: illustrations for cost-effectiveness analysis.
    Postma MJ; Boersma C; Vandijck D; Vegter S; Le HH; Annemans L
    Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):367-9. PubMed ID: 21831013
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Can modern vaccine technology pursue the success of traditional vaccine manufacturing?
    Grabherr R; Reichl U
    Biotechnol J; 2015 May; 10(5):657-8. PubMed ID: 25943526
    [No Abstract]   [Full Text] [Related]  

  • 17. Bad medicine.
    Sheridan C
    Nat Biotechnol; 2007 Jul; 25(7):707-9. PubMed ID: 17621284
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings of the 5th Central European Symposium on Pharmaceutical Technology and Biotechnology. September 25-27, 2003. Ljubljana, Slovenia.
    Int J Pharm; 2005 Mar; 291(1-2):1-219. PubMed ID: 15707725
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine Technology III: an ECI Conference held in Puerto Vallarta, Mexico from June 6-11, 2010.
    Buckland BC; Aunins JG; Jansen K; Alves PM; Weiner D
    Vaccine; 2011 Sep; 29(41):7115-6. PubMed ID: 21689708
    [No Abstract]   [Full Text] [Related]  

  • 20. Personalized medicine: a paradigm for a sustainable pharmaceutical industry?
    Chackalamannil S; Desai MC
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.